Image of hexagons overlapping in different sizes

ICH Q1s/5C Revision – Opportunities in Science and Risk-Based Testing Approaches for Biologics

Home / Papers and Presentations / Resource
Image with text 'CMC Strategy Forum Japan Advancing Biopharmaceutical Development'

Speaker Presentation: CMC Strategy Forum Japan 2025
Zimmermann Boris, Genentech, a Member of the Roche Group, 2025
ICH Q1s/5C Revision – Opportunities in Science and Risk-Based Testing Approaches for Biologics

Related Files